1 Division of Pharmaceutical Cell Biology, Graduate School of Pharmaceutical
Sciences, Kyushu University, Maidashi 3-1-1, Fukuoka 812-8582, Japan
2 Centre for High Resolution Imaging and Processing, University of Dundee,
School of Life Sciences, DD1 5EH Dundee, UK
3 Biochemisches Institut, Universität Kiel, Olshausenstrasse 40, D-24098
Kiel, Germany
* Author for correspondence (e-mail: tanakay{at}bioc.phar.kyushu-u.ac.jp)
Accepted 29 July 2002
![]() |
Summary |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: LGP85, Lysosome, Membrane traffic, Rab5
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
It has been considered that lysosomal membrane proteins have multiple
functions, such as sequestration of numerous acid hydrolases, maintenance of
an acidic intralysosomal environment, transport of degradation products (amino
acids and carbohydrates) from the lysosomal lumen to the cytoplasm, and
specific interaction and fusion between lysosomes and other organelles
(Fukuda, 1991;
Peters and von Figura, 1994
;
Hunziker and Geuze, 1996
). The
limiting membrane of lysosomes contains a characteristic set of highly
glycosylated transmembrane proteins. Based on their amino acid sequences
deduced from cDNA cloning of different species, five major membrane proteins,
LAMP-1, LAMP-2, LAMP-3 (also known as LIMP I or CD63), LGP85 (LIMP II) and
lysosomal acid phosphatase, have been identified. Among them, LAMP-1 and
LAMP-2 are the best characterized lysosomal membrane proteins; they contain a
large luminal domain bearing a number of N-linked oligosaccharide chains, a
single transmembrane anchor, and a short cytoplasmic domain bearing a
tyrosine-based motif, which is necessary and sufficient for their targeting to
lysosomes (Williams and Fukuda,
1990
; Harter and Mellman,
1992
; Guarnieri et al.,
1993
; Höning and
Hunziker, 1995
; Gough and
Fambrough, 1997
; Gough et al.,
1999
).
LGP85 (LIMP II), one of the major lysosomal membrane proteins (Barrinocanal
et al., 1986; Okazaki et al.,
1992), is characterised by a different structure. Unlike LAMP-1
and LAMP-2, which are type I membrane proteins, LGP85 is a type III membrane
protein that is inserted into the intracellular membrane by an N-terminal
uncleavable signal sequence and a short C-terminal domain
(Vega et al., 1991
;
Fujita et al., 1991
;
Fujita et al., 1992
). In
addition, the signal responsible for targeting of LGP85 to lysosomes is also
different. Instead of a tyrosine-based motif, a di-leucine-based motif present
in the C-terminal cytoplasmic domain mediates effective lysosomal targeting
(Ogata and Fukuda, 1994
;
Sandoval et al., 1994
).
So far, two different pathways for transport of newly synthesized lysosomal
membrane proteins have been proposed (reviewed by
Hunziker and Geuze, 1996). One
of them is the direct intracellular route that delivers these proteins from
the TGN to lysosomes via endosomes. The other is the indirect route in which
newly synthesized lysosomal membrane proteins are transported from the TGN to
the plasma membrane and subsequently delivered to lysosomes via the endocytic
pathway. In both, direct and indirect intracellular routes, trafficking and
sorting of lysosomal membrane proteins are mediated by distinct
heterotetrameric adaptor complexes. Four adaptor complexes, AP-1, AP-2, AP-3,
and AP-4, and GGAs have been described and are thought to function in the
transport of cargo proteins into the endocytic and lysosomal pathways
(reviewed by Kirchhausen,
1999
; Robinson and Bonifacino,
2001
). Recent studies have pointed to a participation of AP-3 in
sorting of several lysosomal membrane proteins including LAMPs and LGP85 (LIMP
II) to lysosomes from the TGN or endosomes using both tyrosine- and
di-leucine-based sorting motifs
(Höning et al., 1998
;
Le Borgne et al., 1998
;
Dell'Angelica et al.,
1999
).
Several lines of evidence in vivo and in vitro have revealed that late
endosomes and lysosomes undergo multiple cycles of fusion and fission
(Storrie and Desjardins, 1996;
Futter et al., 1996
;
Bright et al., 1997
;
Mullock et al., 1998
;
Luzio et al., 2000
). This
implies that late endosomes and lysosomes are in dynamic equilibrium with each
other (Mellman, 1996
). This
could explain why all lysosomal membrane proteins reside both in late
endosomes and lysosomes. In vitro fusion experiments have identified several
different molecules, such as NSF, SNAPs and Rab GDI-sensitive GTPase, to be
involved in fusion between late endosomes and lysosomes
(Mullock et al., 1998
).
However, the precise molecular mechanisms responsible for late
endosome-lysosome fusion have not yet been established. Despite the extensive
knowledge regarding intracellular traffic of lysosomal membrane proteins,
there is still no direct evidence whether lysosomal membrane proteins are
involved in membrane traffic between late endosomes and lysosomes. If
overexpression of lysosomal membrane proteins causes morphological changes in
late endosomes and/or lysosomes by perturbing membrane equilibrium between
these compartments, it could be possible that lysosomal membrane proteins
themselves are involved in the membrane traffic between late endosomes and
lysosomes directly or indirectly as components of a machinery
regulating docking/fusion or fission.
In the present work, we have overexpressed several lysosomal membrane proteins in COS cells and analyzed their effect on the morphology and membrane traffic of the endosomal/lysosomal system. We show that overexpression of LGP85 specifically results in large swollen vacuoles, which have characteristics of endosomes and lysosomes. We also show perturbation of membrane traffic out of, and accumulation of free-cholesterol in, these enlarged endosomal and lysosomal compartments. Together with an inhibitory effect of the dominant-negative form of Rab5b on the formation of large vacuoles induced by overexpression of LGP85, we conclude that LGP85 may be involved in the biogenesis of endosomes/lysosomes and in the reorganization of the endosomal/lysosomal compartments, presumably through the interaction with a machinery regulating vesicular fusion or fission.
![]() |
Materials and Methods |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Antibodies
Rabbit polyclonal antibodies to rat LGP85 were raised against the purified
LGP85 from isolated rat liver lysosomal membranes
(Okazaki et al., 1992). Mouse
monoclonal antibodies to rat LGP85 and LGP96 were kindly provided from Kenji
Akasaki (Fukuyama University, Japan). Rabbit polyclonal antibodies to rat
LGP107 have been previously described
(Furuno et al., 1989a
). Mouse
monoclonal antibodies to human LAMP-2 were obtained from the Developmental
Studies Hybridoma Bank maintained by the University of Iowa (Iowa City, IA).
Mouse monoclonal antibodies to early endosome autoantigen 1 (EEA1) and GM130
were purchased from Transduction Laboratories (Lexington, KY). Mouse
monoclonal antibodies to human Tfn receptor (TfnR) were obtained from Zymed
Laboratories (San Francisco, CA). Mouse monoclonal antibodies to FLAG M2 were
purchased from Sigma. Mouse monoclonal antibodies to lysobisphosphatidic acid
(LBPA) were a kind gift of Toshihide Kobayashi (RIKEN, Tokyo). Rabbit
polyclonal antibodies to rat cation-independent mannose
6-phosphate/insulin-growth factor II receptor (MPR300) were raised against a
fusion protein encoding glutathion S-transferase coupled to a portion of the
cytoplasmic tail (amino acids 2313 to 2409) of rat MPR300
(MacDonald et al., 1988
).
Cell culture and transfection
COS-1, HeLa, MDCK, NRK and NIH3T3 cells were cultured in DMEM supplemented
with 10% FBS, 2 mM glutamine, and 100 units of penicillin/streptomycin/ml in
humidified 95% air and 5% CO2 at 37°C. The cells were plated
onto 13 mm coverslips the day before transfection. The full-length rat LGP85
(Fujita et al., 1991), rat
LGP107 (Himeno et al., 1989
),
or rat LGP96 (Noguchi et al.,
1989
) cDNA was then inserted into the expression vector pcDNA3.1
(Invitrogen). The human wild-type Rab5b, Rab5bQ79L, and Rab5bS34N cDNAs
inserted into the pCMV5-Flag vector
(Kurosu and Katada, 2001
) were
kindly provided from Kota Saito and Toshiaki Katada (Tokyo University, Japan).
The transfections were carried out with FuGENE6, according to the
manufacturer's instructions. After 36 hours the cells were used for
immunocytochemical experiments.
Immunofluorescence microscopy
Cells cultured on coverslips and transfected with LGP85 were rinsed with
phosphate-buffered saline (PBS), fixed immediately in 4% paraformaldehyde
(PFA) in PBS, pH 7.4, for 15 minutes at room temperature, and permeabilized
with 0.05% saponin in PBS for 15 minutes or methanol for 5 minutes at 0°C
(for EEA1 immunostaining). To label lysosomes, cells cultured on coverslips
were incubated with Texas Red-labeled dextran (1 mg/ml) in serum-free DMEM
with 1 mg/ml BSA for 4 hours at 37°C and then cultured in normal medium
for 20 hours. After that, cells were transfected with LGP85, fixed in 4% PFA
in PBS at 12, 24 or 36 hours post-transfection, and permeabilized with 50
µg/ml digitonin in PBS. Cells were quenched with 50 mM NH4Cl in
PBS for 15 minutes and blocked with 1% bovine serum albumin (BSA) in PBS for
30 minutes. The cells were then incubated for 1 hour in the primary antibody
diluted in blocking solution using the following dilutions of the primary
antibodies: anti-LGP85 antibody (1:3000), anti-LAMP-2 antibody (1:100),
anti-EEA1 antibody (1:100), anti-LBPA antibody (1:100), anti-MPR300 antibody
(1:300), anti-GM130 antibody (1:100), and anti-FLAG antibody (1:300). The
cells were washed with blocking solution and incubated for 30 minutes with the
secondary antibodies diluted in blocking solution. Coverslips were then washed
three times with blocking solution, rinsed with water, and mounted onto glass
slides. Visualization of acidic compartments by
3-(2,4-dinitroanilino)-3'-amino-N-methyldipropylamine (DAMP) was carried
out using the acidic granule kit (Oxford Biomedical Research, MI) according to
the manufacturer's instructions. Fluorescence was viewed using a fluorescence
light microscope (Leica DMRB; Wetzlar, Germany) and a 63x oil immersion
lens. Photographic images were acquired using a cooled CCD camera (MicroMAX;
Princeton Instruments, Trenton, NJ), processed using IPlab software
(Scanalytics, Fairfax, VA), and merged using Adobe Photoshop software (Adobe
Systems, Mountain View, CA). For some experiments, the cells were analyzed by
confocal laser scanning microscopy using a Radiance 2100 MP confocal
microscope (Bio-Rad Laboratories, Richmond, CA) with an argon/krypton laser,
the Red Diode laser, and the Blue Diode laser.
Tfn, EGF and dextran internalization
For Tfn internalization, cells cultured on coverslips and transfected with
LGP85 were incubated in serum-free DMEM with 1 mg/ml BSA for 30 minutes and
then with Alexa-594-labeled Tfn (50 µg/ml) for 30 minutes at 37°C. For
EGF internalization, cells cultured on coverslips and transfected with LGP85
were incubated in serum-free DMEM with 1 mg/ml BSA for 12 hours and then with
EGF, biotinylated, complexed to Texas Red streptavidin (3.3 µg/ml) for 1
hour at 4°C. Cells were then shifted to 37°C for 3 hours to allow
internalization. For dextran internalization, cells cultured on coverslips and
transfected with LGP85 were washed with serum-free DMEM with 1 mg/ml BSA and
then incubated with Texas Redlabeled dextran (1 mg/ml) for 30 minutes at
37°C. After a chase of 3 hours, cells were washed with PBS, fixed in 4%
PFA in PBS, and permeabilized with 50 µg/ml digitonin in PBS, followed by
immunostaining for LGP85, EEA1, or LAMP-2.
Filipin staining
Cells cultured on coverslips and transfected with LGP85 were rinsed with
PBS, fixed in 4% PFA in PBS, pH 7.4, for 30 minutes at room temperature. Cells
were stained (and permeabilized) with 0.05% filipin in PBS for 1 hour,
followed by immunostaining for LGP85.
Immunoelectron microscopy
Cells were cultured on 10 cm plastic dishes and transfected with LGP85.
Monolayers were fixed in 4% paraformaldehyde in 0.2 M Hepes, pH 7.4 for 2
hours at room temperature, and then stored in 2% paraformaldehyde in the same
buffer. The cells were embedded in 10% gelatin, infiltrated with 17%
polyvinylpyrrolidone-1.8 M sucrose, and frozen in liquid nitrogen. Thin frozen
sections were cut at-100°C and picked up with sucrose-methyl cellulose.
The sections were immunolabelled with rabbit anti-LGP85 mixed with either
mouse anti-LAMP-2 or LBPA, followed by a mixture of goat anti-rabbit-10 nm
gold and goat anti-mouse 5 nm gold (British BiCell, Cardiff, UK).
![]() |
Results |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
Appearance of large vacuoles is specific to expression of LGP85
We examined whether the appearance of swollen vacuoles is specific to
expression of LGP85. To this end, either LGP107 (rat LAMP-1) or LGP96 (rat
LAMP-2) cDNA, both of which are well known as late endosome/lysosome markers
(Furuno et al., 1989a;
Furuno et al., 1989b
), was
expressed in COS cells. We have previously isolated lysosomal membranes from
rat liver (Ohsumi et al.,
1983
). We analyzed them on SDS-PAGE and Coomassie blue staining
and found that LGP107 and LGP96 are the most abundant proteins of the
lysosomal membrane. Based on our results, we consider the relative abundance
of lysosomal membrane proteins to be the following:
LGP107=LGP96>LGP85>acid phosphatase> LAMP-3. In contrast to LGP85,
large swollen vacuoles were never observed in cells expressing LGP107 or LGP96
(Fig. 2), indicating that the
formation of large swollen vacuoles is specific to expression of LGP85.
Essentially, identical results were obtained using other cell types described
above (data not shown).
|
Characterization of large vacuolar compartments induced by
overexpression of LGP85
To clarify the characteristics of LGP85-induced large swollen vacuoles, we
carried out double labeling with several well-characterized organelle markers.
LAMP-2, which localizes in both late endosomes and lysosomes, was
predominantly detected on the limiting membrane of LGP85-positive swollen
large vacuoles (Fig. 3A-C).
However, LAMP-2 staining did not completely overlap with LGP85; some
LGP85-positive large vacuoles were always negative for LAMP-2. Similar results
were obtained with LBPA, a late endosome-specific marker
(Kobayashi et al., 1998).
Although LBPA is known to be enriched in internal vesicles of the late
endosome, LBPA staining was predominantly found as punctate structures in
close proximity to or overlapping with LGP85 within or in the vicinity of the
limiting membrane of large vacuoles (Fig.
3D-F). EEA1, a marker for the early endosome
(Mu et al., 1995
), was
localized as small punctate structures throughout the cytoplasm in
untransfected cells. By contrast, expression of LGP85 resulted in an
alteration of EEA1 distribution; most of EEA1 colocalized with LGP85 on the
limiting membrane of large vacuoles (Fig.
3G-I). In this case, however, only a few LGP85-positive large
vacuoles that were located predominantly near the perinuclear region were
stained with EEA1 antibodies. TfnR, an early and recycling endosomes marker,
was also observed in a few LGP85-positive large vacuoles
(Fig. 3J-L) as seen with EEA1
staining. In contrast to these endosomal and lysosomal markers, MPR300, which
localizes in the TGN and late endosomes and cycles between these compartments
(Griffith et al., 1988
;
Stoorvogel et al., 1991
;
Kornfeld, 1992
), was
distributed predominantly in the perinuclear region and was not seen in the
LGP85-induced large vacuoles (Fig.
3M-O). Although MPR300 has also been used as a TGN/late endosome
marker, MPR300 never overlapped with LBPA nor LAMP-2, even in untransfected
cells, suggesting that MPR300 localizes mainly in the TGN in COS cells. This
notion was further supported by the observation that treatment of cells with
BFA, a drug that is known to cause extensive tubulation of the TGN and early
endosomes (Lippincott-Schwartz et al.,
1991
; Wood and Brown,
1992
), altered perinuclear distribution of MPR300 to tubular
staining pattern (data not shown). Similarly, syntaxin 6, a TGN marker
(Bock et al., 1997
) was not
localized in large swollen vacuoles induced by overexpression of LGP85 (data
not shown). GM130, which localizes in cis-Golgi
(Nakamura et al., 1995
),
showed a relatively compact staining pattern located on one side of the
nucleus and did not localize in LGP85-positive large vacuoles
(Fig. 3P-R). Taken together,
these results indicate that overexpression of LGP85 results in an enlargement
of at least two distinct populations of endosomal compartments, early
endosomes and late endosomes/lysosomes. No enlargement of TGN and Golgi
compartment was observed. Therefore, we conclude that overexpression of LGP85
selectively affects endosomal compartments.
|
LGP85-induced large vacuoles are not derived from lysosomes, but
eventually fuse with the preexisting lysosomes
We next investigated the possible involvement of lysosomes in the formation
of large swollen vacuoles by overexpression of LGP85. In order to observe
morphological alteration of lysosomes, cells were first incubated with Texas
Red-dextran for 4 hours and chased for 20 hours to label lysosomes. Then LGP85
was transfected and the cells subjected to immunofluorescence at the indicated
times after transfection. With this procedure, in untransfected cells Texas
Red-dextran exhibited a small punctate staining scattered throughout the cells
and in the perinuclear region, most of which colocalized with endogenous
LAMP-2 (data not shown), suggesting that Texas Red-dextran-containing vesicles
are mainly late endosomes/lysosomes. Interestingly, there was no significant
overlap of preloaded dextran with LGP85 after 12 hours of transfection
(Fig. 4A-C). However, at this
time numerous large vacuoles were already visible by phase-contrast microscopy
in most of the cells overexpressing LGP85, and some of them were positive for
either LAMP-2 or EEA-1 (data not shown), thereby indicating that lysosomes
were not involved in the initial formation of large vacuoles and
overexpression of LGP85 did not cause the enlargement of lysosomes. In cells
fixed 24 hours after transfection of LGP85, significant amounts of preloaded
Texas Red-dextran were seen in LGP85-negative small punctate structures
(Fig. 4D-F). A small number of
LGP85-positive large vacuoles contained Texas Red-dextran, which was seen
within or in the vicinity of the LGP85-positive large vacuoles. These results
suggest that at this time most of LGP85-induced large vacuoles still have
characteristics of late endosomes, but not of lysosomes. A significant
colocalization between LGP85 and preloaded Texas Red-dextran in large swollen
vacuoles was observed in cells 36 hours after transfection
(Fig. 4G-I). Maximum overlap of
the two markers was observed after 36-48 hours of expression. Taken together,
these results suggest that the large vacuoles induced by overexpression of
LGP85 may first arise from homotypic fusion of early and late endosomes,
respectively, and the late endosome-like large vacuoles may gradually fuse
with lysosomes.
|
Most of LGP85-induced large vacuoles are electron lucent
To characterize LGP85-induced large vacuoles in more detail, we performed
immunoelectron microscopic analysis with several antibodies. As shown in
Fig. 5A-C, most of
LGP85-induced large vacuoles seemed empty, displaying the appearance of
swollen vacuoles, consistent with phase-contrast microscopy. The limiting
membrane of these large vacuoles often appeared as double membrane
(Fig. 5A,B, arrowheads).
Membrane whirls and myelin figures were seen inside these large vacuoles.
LAMP-2 labeling was observed mainly on the limiting membrane of the vacuoles
(Fig. 5C). LBPA labeling was
predominantly found associated with the internal membranes, but some labeling
was closely associated with the limiting membrane
(Fig. 5D, arrows). In cells
expressing LGP85 at a very low level (which does not cause the formation of
large vacuoles), LBPA labeling was detected in internal vesicles of MVB
(Fig. 5E), similar to results
reported previously (Kobayashi et al.,
1998). These results suggest that an increase of vesicle fusion
and/or decrease of internal vesicle invagination by overexpression of LGP85
may lead to the formation of large swollen vacuoles.
|
A subset of LGP85-induced large vacuoles is accessible to endocytosed
tracers
To examine whether LGP85-induced large vacuoles are a compartment that is
accessible to endocytic markers, COS cells expressing LGP85 were allowed to
internalize either fluorescence-labeled-Tfn, -EGF, or -dextran. Tfn, which is
bound to its receptor on the cell surface, is internalized via clathrin-coated
vesicles, and is transferred to early endosomes. Receptor-ligand complexes are
rapidly recycled back to the cell surface. Tfn was fed for 30 minutes to cells
transfected with LGP85 (Fig.
6A-C). In untransfected cells, internalized Tfn predominantly
distributed as small punctate structures in the perinuclear and peripheral
regions, presumably representing the recycling endosome and the sorting
endosome, respectively. In contrast, in cells overexpressing LGP85, Tfn was
found in a subset of large swollen vacuoles positive for LGP85, which is
consistent with the results obtained with double-labeling of LGP85 and EEA-1
or TfnR (Fig. 3C).
|
EGF binds to its receptor on the cell surface, and receptorligand complexes are internalized by clathrin-coated vesicles. Unlike Tfn, EGF and its receptor are further transported to lysosomes via endosomes and are finally degraded in lysosomes. Cells transfected with LGP85 were incubated with Texas-Red-labeled EGF for 1 hour at 4°C and chased for up to 3 hours at 37°C. After 3 hours of chase, Texas Red-EGF was seen on the limiting membrane of a subset of LGP85-positive large vacuoles (Fig. 6D-F). The same staining pattern was obtained when Texas-Red dextran was internalized for 3 hours in cells overexpressing LGP85 (Fig. 6G-I). These results indicate that only a subset of LGP85-induced vacuoles is accessible to endocytic markers.
Membrane traffic out of the early endosome is impaired by
overexpression of LGP85
To characterize the nature of the LGP85-induced large vacuoles accessible
for endocytic markers in more detail, we examined the distribution of these
endocytic markers by double labeling with EEA1 or LAMP-2. Alexa-594-labeled
Tfn was internalized for 30 minutes and the cells were fixed and labeled with
either EEA1 (Fig. 7A-D) or
LAMP-2 antibodies (Fig. 7M-P).
In cells expressing LGP85, Alexa-594-labeled Tfn completely colocalized with
EEA1 (Fig. 7A-D), but not with
LAMP-2 (Fig. 7M-P), in large
swollen vacuoles. EGF, which was bound to cell surface receptor for 1 hour at
4°C and chased for 3 hours at 37°C, was also seen only in
EEA1-positive large swollen vacuoles (Fig.
7E-H). In untransfected cells, on the other hand, EGF was observed
in LAMP-2-positive vesicles (Fig.
7Q-T), and never colocalized with EEA1
(Fig. 7E-H). The same results
were obtained with Texas-red dextran (Fig.
7I-L, U-X). Taken together, these results indicate that
overexpression of LGP85 causes not only an enlargement of both early endosomes
and late endosomes/lysosomes but also a defect in membrane traffic from early
endosomes to the late endocytic compartment. Additionally, during a subsequent
3 hours chase after withdrawal of Tfn, most of the internalized Tfn
disappeared from untransfected cells, while significant amounts of the
internalized Tfn were still retained in the LGP85-positive large swollen
vacuoles (data not shown). Therefore, it is evident that the recycling pathway
from the LGP85-induced, enlarged, early endosome-like compartment to the cell
surface is also impaired.
|
The result that both early endosome- and late endosome-like large vacuoles appeared simultaneously leads us to speculate that the enlarged early endosomes are formed by LGP85 molecules that are delivered through an indirect route via the cell surface. If this is the case, antibodies against LGP85 added extracellularly would be taken up and retained in the early endosome-like large vacuoles induced by overexpression of LGP85. As expected, antibodies were internalized only in cells with large swollen vacuoles, in which they colocalized with EEA1, but not with LAMP-2 (Fig. 8). This is consistent with the results obtained with endocytic markers, such as Tfn, EGF and dextran. Thus, the LGP85 in early endosome-like large vacuoles may reach the endosomes through the indirect pathway of newly synthesized LGP85 via the cell surface.
|
Cholesterol accumulates in large swollen vacuoles induced by
overexpression of LGP85
Several recent studies demonstrated that accumulation of cholesterol in
late endosomes/lysosomes causes a defect of subsequent retrograde and
anterograde membrane traffic (Kobayashi et
al., 1999; Neufeld et al.,
1999
). Therefore, we examined the distribution of cellular
cholesterol in LGP85-expressing cells using filipin, a specific antibiotic
against free-cholesterol (Blanchette-Mackie
et al., 1988
). It is known that free-cholesterol predominantly
distributes on the cell surface as well as the Golgi
(Mukherjee and Maxfield,
2000
). Indeed, in untransfected cells filipin staining was
detected on the cell surface and in the perinuclear region
(Fig. 9C). By contrast,
overexpression of LGP85 dramatically altered filipin staining to the large
vacuoles in which LGP85 was located (Fig.
9A-D). Neither LGP107 nor LGP96 expression caused accumulation of
cholesterol in the late endosome/lysosome (data not shown).
|
To further examine whether the cholesterol accumulating in LGP85-positive large vacuoles is derived from lipoproteins in serum, cells were cultured for 24 hours in lipoprotein-deficient serum (LPDS) and transfected with LGP85 in a medium containing LPDS. As shown in Fig. 9E-H, large vacuoles were formed even in the presence of LPDS. There was no difference in filipin staining compared with normal medium. These results indicate that cholesterol found in LGP85-positive large vacuoles derives from either the cell surface or de novo synthesis in cells rather than from extracellular lipoproteins such as LDL. Therefore, it may be conceivable that the block of traffic out of the endosomal/lysosomal compartments in LGP85-expressing cells causes the accumulation of cholesterol in these compartments.
LGP85-induced large vacuoles are acidic
Lysosomotropic amines, such as NH4Cl and methylamine, have been
shown to cause vacuolation of acidic compartments
(Ohkuma and Poole, 1981;
Davis and Lyerla, 1997
). The
effect of these amines is due to raising the pH of intra-endosomal/lysosomal
compartments by accumulation of protonated base
(Ohkuma and Poole, 1981
).
However, the LGP85-induced large vacuoles were found to be acidic compartments
as judged by staining with DAMP (data not shown), which is a basic congener of
dinitropheol and accumulates in acidic organelles
(Anderson et al., 1984
).
Specificity of the DAMP staining was demonstrated by showing that when cells
were pretreated with 50 mM NH4Cl before incubating with DAMP, the
DAMP staining was no longer detected in the LGP85-induced large vacuoles nor
elsewhere within the cells. In addition to the fact that the vacuolar size in
NH4Cl-treated cells is much smaller than that in
LGP85-overexpressing cells (data not shown), these results imply that
mechanism(s) responsible for the formation of large vacuolar compartments by
overexpression of LGP85 differ from that by lysosomotropic amines.
Expression of dominant-negative Rab5b impairs the formation of large
vacuoles by overexpression of LGP85
Rab GTPases are known to play key roles in regulation of membrane traffic
in the endosomal/lysosomal system (Zerial
and McBride, 2001). Recent studies have implicated Rab7 and Rab5a
in the biogenesis of lysosomes (Bucci et
al., 2000
; Rosenfeld et al.,
2001
). Especially, expression of a GTPase-defective Rab5a
(Rab5aQ79L) caused appearance of large vacuoles, which contain several
lysosomal marker proteins including LAMP-1, LAMP-2 and cathepsin D
(Rosenfeld et al., 2001
). In
an attempt to learn more about the mechanism(s) by which LGP85 induces the
enlargement of endosomes/lysosomes, we examined the involvement of Rab5.
Consistent with results previously reported
(Rosenfeld et al., 2001
), we
observed that expression of FLAG-tagged GTPase-defective Rab5b (Rab5bQ79L) in
COS cells caused the formation of LAMP-1-positive large vacuoles (data not
shown). Interestingly, co-transfection of FLAG-tagged dominant-negative Rab5b
(Rab5bS34N) and LGP85 in COS cells impaired the formation of large vacuoles,
leading to dispersal of LGP85-positive small vacuoles throughout the cytoplasm
(Fig. 10C,D). By contrast,
wild-type Rab5b (Rab5bWT) did not influence the formation of large vacuoles
induced by overexpression of LGP85 (Fig.
10A,B). Rather, cotransfection of Rab5bWT and LGP85 exhibited a
tendency to increase the size of and decrease the number of the vacuoles
(Fig. 10A,B), which was
significantly enhanced by cotransfection with Rab5bQ79L (data not shown).
These results suggest the participation of a GTP-bound form of Rab5b in the
formation of large vacuoles induced by overexpression of LGP85.
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Similar large vacuoles have been observed when the invariant chain (Ii) was
expressed (Romagnoli et al.,
1993; Stang and Bakke,
1997
). Although a transient expression of the Ii in COS cells
caused mainly the enlargement of the early endosome
(Romagnoli et al., 1993
), a
stable expression of Ii in human fibroblasts induced the enlargement of early
endosomes, late endosomes/prelysosomes and lysosomes
(Stang and Bakke, 1997
). These
enlarged endosomal vacuoles were accessible for fluid phase markers, but a
delay of their endosome to lysosome transport was observed. The Ii
expression-induced, early endosome-like vacuoles appear to be formed by the
indirect transport route of newly synthesized Ii via the cell surface
(Stang and Bakke, 1997
).
Therefore, most of the enlarged vacuoles induced by Ii were negative for LAMP.
It is conceivable that the enlarged late endosomes and lysosomes observed in
cells stably expressing Ii might be a result of the maturation of the enlarged
early endosomes.
By contrast, it seems unlikely that in cells overexpressing LGP85 the enlarged late endosome/lysosome-like vacuole resulted from the maturation of the early endosome-like vacuole. Such a conclusion is supported by the following results: (1) both types of vacuoles appeared simultaneously; (2) membrane traffic from the early endosome-like vacuoles to the late endosome/lysosome-like vacuole was not detected; (3) most of the enlarged vacuoles were positive for LAMP-2. Rather, as antibodies against LGP85 fed extracellularly were internalized and colocalized with EEA1-positive, but not with LAMP-2-positive large swollen vacuoles, the early endosome-like vacuoles observed in COS cells may arise due to excessive supply of LGP85 from the cell surface to early endosomes, which may be a consequence of missorting from the TGN by overexpression. It is also possible that increased fusion of LGP85-containing TGN-derived vesicles with pre-existing early endosomes might facilitate the formation of these large vacuoles.
Overexpression of LGP85 did not cause an enlargement of lysosomes that were
labeled by preloading dextran before transfection of LGP85. Indeed, preloaded
dextran did not colocalize with LGP85-induced, LBPA- and LAMP-2-positive,
large vacuoles already formed at 12 hours post-transfection, indicating that
there is no direct involvement of lysosomes in the initial formation of large
vacuoles. Our results further showed that lysosomes fuse with the preformed
enlarged LBPA and LAMP-2-positive vacuoles. These results may reflect that
LGP85-induced large vacuoles are formed first by homotypic fusion of late
endosomes, and gradually tend to fuse with lysosomes. Thus, LGP85-induced late
endosome/lysosome-like vacuoles seem to resemble the hybrid organelle, which
is transiently formed by direct fusion between the late endosome and the
lysosome (Bright et al.,
1997).
The late endosome-lysosome hybrid organelle was originally identified in
cells treated with the phosphoinositide (PI) 3-kinase inhibitor, wortmannin
(Reaves et al., 1996).
Wortmannin causes enlargement of late endocytic/prelysosomal compartments, but
not of lysosomes containing acid hydrolases, as well as redistribution of
lysosomal membrane proteins (lgp120 and lgp110) to enlarged late endosomes
from lysosomes. However, prolonged treatment of cells with wortmannin (5
hours) eventually resulted in direct fusion between swollen endosomes and
lysosomes and concomitant decrease of dense core lysosomes
(Bright et al., 1997
). Thus, it
has been suggested that wortmannin causes an accumulation of late
endosome-lysosome hybrid organelles as a result of the inhibition of membrane
traffic out of the hybrid organelles (e.g. inhibition of reformation of
lysosomes). Similarly, we could not detect reformation of lysosomes in cells
overexpressing LGP85. We conclude that accumulation of LGP85 in the endosomal
compartment could interfere with vesicle budding without inhibiting the
vesicle fusion event, leading to the enlargement of this compartment.
The block of traffic out of LGP85-induced large vacuoles may correlate with
the accumulation of cholesterol in these structures. There is considerable
evidence to support a role for cholesterol as an important molecule in the
context of the intracellular membrane traffic: accumulation of cholesterol
into late endosomes/lysosomes by administrating antibodies to LBPA
(Kobayashi et al., 1999) and
by mutating the Niemann-Pick type C disease gene
(Neufeld et al., 1999
) leads
to impairment of membrane traffic out of these compartments. Expression of an
ATPase-defective form of human Vps4p, which is the mammalian homologue of
yeast Vps4p required for endosomal trafficking
(Babst et al., 1998
), has also
been known to cause not only enlargement of multiple endosomal compartments
and defects in postendosomal sorting, but also accumulation of cholesterol in
these compartments (Bishop and Woodman,
2000
), consistent with phenotypes induced by overexpression of
LGP85. Authors have pointed out that the phenotype observed in the cells
expressing mutant human Vps4p is strikingly similar to that induced by
wortmannin.
In addition to the inhibition of reformation of lysosomes, wortmannin has
been proposed to induce enlargement of late endosomes and lysosomes by
inhibiting exit of proteins such as MPR
(Kundra and Kornfeld, 1998) or
invagination and/or pinching off of intraluminal vesicles
(Fernandez-Borja et al., 1999
;
Futter et al., 2001
). It was
indicated that class III PI 3-kinase, the human VPS34, is indeed involved in
inward vesiculation, suggesting a role for PtdIns3P in the regulation
of MVB morphogenesis. Besides the early requirement for PtdIns3P as a
regulator of vesicle docking/fusion at the endosome through the
recruitment/activation of components in the PI 3-kinase signaling cascade
(Lemmon and Traub, 2000
;
Odorizzi et al., 2000
;
Simonsen et al., 2001
), the
generation of PtdIns(3,5)P2 from PtdIns3P is also
required for the vesicle invagination and/or cargo selection within the MVBs
(Odorizzi et al., 1998
).
Indeed, in yeast, the loss of Fab1p, a protein previously identified in yeast
as PtdIns3P 5-kinase, which phosphorylates PtdIns3P to
produce PtdIns(3,5)P2, causes an abnormally large swollen
vacuole containing far fewer internal vesicles
(Gary et al., 1998
). It has
recently been demonstrated that PIKfyve, a mammalian ortholog of Fab1p
(Shisheva et al., 1999
;
McEwen et al., 1999
),
localizes on MVBs (Shisheva et al.,
2001
), and transient expression of a kinase-deficient point mutant
of PIKfyve (PIKfyveK1831E) in COS cells results in multiple large
swollen vacuoles that originate from late endosomes
(Ikonomov et al., 2001
).
PIKfyveK1831E-induced vacuoles have diameters of 5-10 µm, and
increase in size and decrease in number with increasing time
post-transfection. Such dominant phenotypes observed with
PIKfyveK1831E are very similar to those induced by overexpression
of LGP85 presented in this study, thereby suggesting that a common mechanism
might be involved. We observed that the LGP85-induced large vacuoles were
morphologically indistinguishable from those induced by wortmannin treatment
(data not shown). Immunoelectron microscopy further showed that most, but not
all, of LGP85-induced large vacuoles have few internal membranous structures.
Thus it is possible that overexpression of LGP85 impaired the formation of
MVB. One possibility is that overexpression of LGP85 may cause the formation
of large swollen vacuoles by decreasing internal vesicle formation from the
limiting membrane, possibly by inhibiting the membrane recruitment of
PI3-kinase and/or PIKfyve.
Nevertheless, our results that EEA1 is associated with the membrane of the
LGP85-induced large vacuoles suggests that PtdIns3P is present in
these vacuoles. EEA1 binds to endosomal membranes through interaction with
PtdIns3P and is released from the membrane by wortmannin treatment
(Simonsen et al., 1998).
Therefore, overexpression of LGP85 may not exert the generation of
PtdIns3P itself. The efficient recruitment of EEA1 on early endosomes
requires the concomitant presence of Rab5 and PtdIns3P
(Christoforidis et al.,
1999a
). Furthermore, the GTP-bound form of Rab5 specifically
interacts with class I and III PI 3-kinases (Christoforides et al., 1999b).
However, there is evidence that the presence of excess activated Rab5 on the
membrane can compensate the membrane association of EEA1 for the lack of
PtdIns3P in the presence of wortmannin
(Simonsen et al., 1998
).
Recent studies further indicate that the enlarged endosomes induced by
wortmannin are the same endosomes induced by Rab5Q79L, and suggest that
wortmannin can stimulate Rab5 activity by blocking the interaction between
Rab5 and p120 Ras GAP, a Rab5 GTPase-activating protein, rather than
inhibiting PI 3-kinase (Chen and Wang,
2001
). We observed a dot-like staining pattern of EEA1 on the
LGP85-induced large vacuolar membranes. This staining pattern is reminiscent
of that observed in enlarged early endosomes by expression of Rab5Q79L,
representing membrane microdomains, which function as tethering platforms for
incoming vesicles (McBride et al.,
1999
). We further found that expression of the dominant-negative
mutant of Rab5b abolishes the formation of LGP85-induced large vacuoles. These
findings led to the suggestion that enhanced Rab5b activation in the cells
overexpressing LGP85 may facilitate the formation of large vacuoles through
stimulation of endosome-endosome fusion. It is interesting to note that
expression of the dominant-negative mutant of Rab5b impaired the formation of
not only early endosome-like but also late endosome/lysosome-like large
vacuoles induced by overexpression of LGP85, because Rab5 is known to
participate in homotypic fusion of early endosomes
(Gorvel et al., 1991
;
Bucci et al., 1992
). It has
recently been reported, however, that expression of Rab5aQ79L causes
redistribution of lysosomal proteins into Rab5aQ79L-positive enlarged
vacuoles, in which Tfn is rapidly internalized
(Rosenfeld et al., 2001
).
Thus, together with our findings, it is conceivable that Rab5 plays a crucial
role in the biogenesis of lysosomes, which may need appropriate membrane
traffic from, or maturation of, early endosomes. In contrast to LGP85,
expression of Rab5bQ79L did not cause accumulation of cholesterol in the
enlarged endosomal compartments (data not shown); therefore, additional
molecule(s) could be involved in the formation of LGP85-induced large
vacuoles. In fact, evidence that at least 20 proteins directly or indirectly
interact with the GTP-bound form of Rab5 (Christoforidis et al., 1999)
suggests that the machinery downstream of this GTPase is extremely
complex.
At present we have no direct evidence for the molecular mechanism that
leads to the block in transport and enlargement of endosomal/lysosomal
compartments by overexpression of LGP85. However, it is likely that the
cytoplasmic tail and/or the transmembrane domain of LGP85 might be involved.
So far, there are no proteins that are known to interact with the
transmembrane domain, while it has been demonstrated that AP-3 can interact
with the cytoplasmic tail of LGP85
(Höning et al., 1998).
The identification of binding partners for LGP85 by two-hybrid or
co-immunoprecipitation studies should help to shed light on the molecular
mechanism(s) by which LGP85 regulates the biogenesis of lysosomes.
We conclude that LGP85 might control the balance between vesicle invagination versus vesicle budding from the limiting membrane of endosomal compartments. Since the formation of large vacuoles was dependent on the expression level of LGP85, it is possible that overexpression of LGP85 may cause a dispersal of the budding machinery, which might be due to impaired recruitment of a cytoplasmic factor involved in vesicular fission and/or fusion. LGP85 may play a key role in regulating the late endosomal/lysosomal compartment, possibly as one of the components of molecular machinery necessary for the intercompartmental membrane trafficking along the endocytic pathway rather than as a constituent of late endosomes and lysosomes. To our knowledge, this is the first report of a role for LGP85 in the biogenesis and maintenance of endosomes/lysosomes.
![]() |
Acknowledgments |
---|
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Anderson, R. G. W., Falck, J. R., Goldstein, J. L. and Brown, M. S. (1984). Visualization of acidic organelles in intact cells by electron microscopy. Proc. Natl. Acad. Sci. USA 81,4838 -4842.[Abstract]
Babst, M., Wendland, B., Estepa, E. J. and Emr, S. D.
(1998). The Vps4p AAA ATPase regulates membrane association of a
Vps protein complex required fro normal endosome function. EMBO
J. 17,2982
-2993.
Barriocanal, J., Bonifacino, J., Yuan, L. and Sandoval, I.
V. (1986). Biosynthesis, glycosylation, movement through the
Golgi system, and transport to lysosomes by an N-linked
carbohydrate-independent mechanism of three lysosomal integral membrane
proteins. J. Biol. Chem.
261,16755
-16763.
Bishop, N. and Woodman, P. (2000).
ATPase-defective mammalian VPS4 localizes to aberrant endosomes and impairs
cholesterol trafficking. Mol. Biol. Cell
11,227
-239.
Blanchette-Mackie, E. J., Dwyer, N. K., Amende, L. M., Kruth, H. S., Butler, J. D., Sokol, J., Comly, M. E., Vanier, M. T., August, J. T., Brady, R. O. and Pentchev, P. G. (1988) Type-C Niemann-Pick disease: low density lipoprotein uptake is associated with premature cholesterol accumulation in the Golgi complex and excessive cholesterol storage in lysosomes. Proc. Natl. Acad. Sci. USA 85,8022 -8026.[Abstract]
Bock, J. B., Klumperman, J., Davanger, S. and Scheller, R. H. (1997). Syntaxin 6 functions in trans-Golgi network vesicle trafficking. Mol. Biol. Cell 8,1261 -1271.[Abstract]
Bright, N. A., Reaves, B. J., Mullock, B. M. and Luzio, J.
P. (1997). Dense core lysosomes can fuse with late endosomes
and are re-formed from the resultant hybrid organelles. J. Cell
Sci. 110,2027
-2040.
Bucci, C., Parton, R. g., Mather, I. H., Stunnenberg, H., Simons, K., Hoflack, B. and Zerial, M. (1992). The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell 70,715 -728.[Medline]
Bucci, C., Thomsen, P., Nicoziani, P., McCarthy, J. and van
Deurs, B. (2000). Rab7: a key to lysosome biogenesis.
Mol. Biol. Cell 11,467
-480.
Chen, X. and Wang, Z. (2001). Regulation of
epidermal growth factor receptor endocytosis by wortmannin through activation
of Rab5 rather than inhibition of phosphatidylinositol 3-kinase.
EMBO Rep. 2,842
-849.
Christoforidis, S., McBride, H. M., Burgoyne, R. D. and Zerial, M. (1999a). The Rab5 effector EEA1 is a core component of endosome docking. Nature 397,621 -625.[CrossRef][Medline]
Christoforidis, S., Miaczynska, M., Ashman, K., Wilm, M., Zhao, L., Yip, S. C., Waterfield, M. D., Backer, J. M. and Zerial, M. (1999b). Phosphatidylinositol-3-OH kinases are Rab5 effector. Nat. Cell Biol. 1,249 -252.[CrossRef][Medline]
Davis, S. G. and Lyerla, T. A. (1997). The effect of lysosomotropic amines on beige mouse cells. Exp. Cell Res. 237,242 -246.[Medline]
Dell'Angelica, E. C., Shotelersuk, V., Anguilar, R. C., Gahl, W. A. and Bonifacino, J. S. (1999). Altered trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A subunit of the AP-3 adaptor. Mol. Cell 3, 11-21.[Medline]
de Duve, C. (1983). Lysosomes revisited. Eur. J. Biochem. 137,391 -397.[Abstract]
Felder, S., Miller, K., Moehren, G., Ullich, A., Schlessinger, J. and Hopkins, C. R. (1990). Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body. Cell 61,623 -634.[Medline]
Fernandez-Borja, M., Wubbolts, R., Calafat, J., Janssen, H., Divecha, N., Dusseljee, S. and Neefjes, J. (1999). Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr. Biol. 9,55 -58.[CrossRef][Medline]
Fujita, H., Ezaki, J., Noguchi, Y., Kono, A., Himeno, M. and Kato, K. (1991). Isolation and sequencing of a cDNA clone encoding 85kDa sialoglycoprotein in rat liver lysosomal membranes. Biochem. Biophys. Res. Commun. 178,444 -452.[Medline]
Fujita, H., Takata, K., Kono, A., Tanaka, Y., Takahashi, K. Himeno, M. and Kato, K. (1992). Isolation and sequencing of a cDNA clone encoding the 85kDa human lysosomal sialoglycoprotein (hLGP85) in human metastatic pancreas islet tumor cells. Biochem. Biophys. Res. Commun. 184,604 -611.[Medline]
Fukuda, M. (1991). Lysosomal membrane
glycoproteins. Structure, biosynthesis, and intracellular trafficking.
J. Biol. Chem. 266,21327
-21330.
Furuno, K., Ishikawa, T., Akasaki, K., Yano, S., Tanaka, Y., Yamaguchi, Y., Tsuji, H., Himeno, M. and Kato, K. (1989a). Morphological localization of a major lysosomal membrane glycoprotein in the endocytic membrane system. J. Biochem. (Tokyo) 106,708 -716.[Abstract]
Furuno, K., Yano, S., Akasaki, K., Tanaka, Y., Yamaguchi, Y., Tsuji, H., Himeno, M. and Kato, K. (1989b). Biochemical analysis of the movement of a major lysosomal membrane glycoprotein in the endocytic membrane system. J. Biochem. (Tokyo) 106,717 -722.[Abstract]
Futter, C. E., Pearse, A., Hewlett, L. J. and Hopkins, C. R. (1996). Multivesicular endosomes containing internalized EGF-EGF receptor complexes mature and then fuse directly with lysosomes. J. Cell Biol. 132,1011 -1023.[Abstract]
Futter, C. E., Collinson, L. M., Backer, J. M. and Hopkins, C.
R. (2001). Human VPS34 is rewuired for intenal vesicle
formation within multivesicular endosomes. J. Cell
Biol. 155,1251
-1263.
Gary, J. D., Wurmser, A. E., Bonangelino, C. J., Weisman, L. S.
and Emr, S. D. (1998). Fab1p is essential for Ptdlns(3)P
5-kinase activity and the maintenance of vacuolar size and membrane
homeostasis. J. Cell Biol.
143, 65-79.
Gorvel, J. P., Chavrier, P., Zerial, M. and Gruenberg, J. (1991). Rab5 controls early endosome fusion in vitro. Cell 64,915 -925.[Medline]
Gough, N. R. and Fambrough, D. M. (1997).
Different steady state subcellular distributions of the three splice variants
of lysosome-associated membrane protein LAMP-2 are determined largely by the
COOH-terminal amino acid residue. J. Cell Biol.
137,1161
-1169.
Gough, N. R., Zweifel, M. E., Martinez-Augustin, O., Augilar, R.
C., Bonifacino, J. S. and Fambrough, D. M. (1999).
Utilization of the indirect lysosome targeting pathway by lysosome-associated
membrane proteins (LAMPs) is influenced largely by the C-terminal residue of
their GYXX targeting signals. J. Cell Sci.
112,4257
-4269.
Griffith, G., Hoflack, B., Simons, K., Mellman, I. and Kornfeld, S. (1988). The mannose 6-phosphate receptor and the biogenesis of lysosomes. Cell 52,329 -341.[Medline]
Gruenberg, J. and Maxfield, F. R. (1995). Membrane transport in the endocytic pathway. Curr. Opin. Cell Biol. 7,552 -563.[CrossRef][Medline]
Guarnieri, F. G., Arterburn, L. M., Penno, M. B., Cha, Y. and
August, J. T. (1993). The motif Tyr-X-X-hydrophobic residue
mediates lysosomal membrane targeting of lysosome-associated membrane protein
1. J. Biol. Chem. 268,1941
-1946.
Harter, C. and Mellman, I. (1992). Transport of the lysosomal membrane glycoprotein lgp120 (lgp-A) to lysosomes does not require appearance on the plasma membrane. J. Cell Biol. 117,311 -325.[Abstract]
Himeno, M., Noguchi, Y., Sasaki, H., Tanaka, Y., Furuno, K., Kono, A., Sakaki, Y. and Kato, K. (1989). Isolation and sequencing of a cDNA clone encoding 107kDa sialoglycoprotein in rat liver lysosomal membranes. FEBS Lett. 244,351 -356.[CrossRef][Medline]
Höning, S. and Hunziker, W. (1995). Cytoplasmic determinants involved in direct lysosomal sorting, endocytosis, and basolateral targeting of rat lgp120 (lamp-1) in MDCK cells. J. Cell Biol. 128,321 -332.[Abstract]
Höning, S., Sandval, I. V. and von Figura, K.
(1998). A di-leucine-based motif in the cytoplasmic tail of LIMP
II and tyrosinase mediates selective binding of AP-3. EMBO
J. 17,1304
-1314.
Hunziker, W. and Geuze, H. J. (1996). Intracellular trafficking of lysosomal membrane proteins. BioEssays 18,379 -389.[Medline]
Ikonomov, O. C., Sbrissa, D. and Shisheva, A.
(2001). Mammalian cell morphology and endocytic membrane
homeostasis require enzymatically active phosphoinositide 5-kinase PIKfyve.
J. Biol. Chem. 276,26141
-26147.
Kirchhausen, T. (1999). Adaptors for clathrin-mediated traffic. Annu. Rev. Cell Dev. Biol. 15,705 -732.[CrossRef][Medline]
Kobayashi, T., Stang, E., Fang, K. S., de Moerloose, P., Parton, R. G. and Gruenberg, J. (1998). A lipid associated with the antiphospholipid syndrome regulates endosome structure and function. Nature 392,193 -197.[CrossRef][Medline]
Kobayashi, T., Beuchat, M.-H., Lindsay, M., Frias, S., Palmiter, R. D., Sakuraba, H., Parton, R. G. and Gruenberg, J. (1999). Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nat. Cell Biol. 1, 113-118.[CrossRef][Medline]
Kornfeld, S. (1992). Structure and function of the mannose 6-phosphate insulin-like growth factor II receptors. Annu. Rev. Biochem. 61,307 -330.[CrossRef][Medline]
Kornfeld, S. and Mellman, I. (1989). The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5, 483-525.[CrossRef]
Kundra, R. and Kornfeld, S. (1998). Wortmannin
retards the movement of the mannose 6-phosphate/insulin-like growth factor II
receptor and its ligand out of endosomes. J. Biol.
Chem. 273,3848
-3853.
Kurosu, H. and Katada, T. (2001). Association of phosphatidylinositol 3-kinase composed of p110ß-catalytic and p85-regulatory subunits with the small GTPase Rab5. J. Biochem. (Tokyo) 130,73 -78.[Abstract]
Le Borgne, R., Alconada, A., Bauer, U. and Hoflack, B.
(1998). The mammalian AP-3 adaptor-like complex mediates the
intracellular transport of lysosomal membrane glycoproteins. J.
Biol. Chem. 273,29451
-29461.
Lemmon, S. K. and Traub, L. M. (2000). Sorting in the endosomal system in yeast and animal cells. Curr. Opin. Cell Biol. 12,457 -466.[CrossRef][Medline]
Lippincott-Schwartz, J., Yuan, L., Tipper, C., Amherdt, M., Orci, L. and Klausner, R. D. (1991). Brefeldin A's effects on endosomes, lysosomes and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67,601 -616.[Medline]
Luzio, J., Rous, B. A., Bright, N. A., Pryor, P. R., Mullock, B.
M. and Piper, R. C. (2000). Lysosome-endosome fusion and
lysosome biogenesis. J. Cell Sci.
113,1515
-1524.
MacDonald, R. G., Pfeffer, S. R., Coussens, L., Tepper, M. A., Brocklebank, C. M., Mole, J. E., Anderson, J. K., Chen, E., Czech, M. P. and Ullrich, A. (1988). A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 239,1134 -1137.[Medline]
McBride, H. M., Rybin, V., Murphy, C., Giner, A., Teasdale, R. and Zerial, M. (1999). Oligomeric complexes link Rab5 effectors with NSF and drive membrane fusion via interactions between EEA1 and syntax in 13. Cell 98,377 -386.[Medline]
McEwen, R. K., Dove, S. K., Cooke, F. T., Painter, G. F.,
Holmes, A. B., Shisheva, A., Ohya, Y., Parker, P. J. and Michell, R. H.
(1999). Complementation analysis in PtdInsP Kinase-deficient
yeast mutants demonstrates that Schizosaccharomyces pombe and murine Fab1p
homologues are phosphatidylinositol 3-phosphate 5-kinases. J. Biol.
Chem. 274,33905
-33912.
Mellman, I. (1996). Endocytosis and molecular sorting. Annu. Rev. Cell Dev. Biol. 12,575 -625.[CrossRef][Medline]
Mu, F. T., Callaghan, J. M., Steele-Mortimer, O., Stenmark, H.,
Parton, R. G., Campbell, P. L., McCluskey, J., Yeo, J. P., Tock, E. P. and
Toh, B. H. (1995). EEA1, an early endosome-associated
protein. EEA1 is a conserved alpha-helical peripheral membrane protein flanked
by cysteine "fingers" and contains a calmodulin-binding IQ motif.
J. Biol. Chem. 270,13503
-13511.
Mukherjee, S. and Maxfield, F. R. (2000). Role of membrane organization and membrane domains in endocytic lipid trafficking. Traffic 1,203 -211.[CrossRef][Medline]
Mullock, B. M., Bright, N. A., Fearon, C. W., Gray, S. R. and
Luzio, J. P. (1998). Fusion of lysosomes with late endosomes
produces a hybrid organelle of intermediate density and is NSF dependent.
J. Cell Biol. 140,591
-601.
Nakamura, N., Raboville, C., Watson, R., Nilsson, T., Hui, P., Slusarewicz, N., Kreis, T. H. and Warren, G. (1995). Characterization of a cis-Golgi matrix protein, GM130. J. Cell Biol. 131,1715 -1726.[Abstract]
Neufeld, E. B., Wastney, M., Patel, S., Suresh, S., Cooney, A.
M., Dwyer, N. K., Roff, C. F., Ohno, K., Morris, J. A., Carstea, E. D. et
al. (1999). The Niemann-Pick C1 protein resides in a
vesicular compartment linked to retrograde transport of multiple lysosomal
acrgo. J. Biol. Chem.
274,9627
-9635.
Noguchi, Y., Himeno, M., Sasaki, H., Tanaka, Y., Kono, A., Sakaki, Y. and Kato, K. (1989). Isolation and sequencing of a cDNA clone encoding 96kDa sialoglycoprotein in rat liver lysosomal membranes. Biochem. Biophys. Res. Commun. 164,1113 -1120.[Medline]
Odorizzi, G., Babst, M. and Emr, S. D. (1998). Fab1p Ptdlns(3)P 5-kinase function essential for protein sorting in the multivesicular body. Cell 95,847 -858.[Medline]
Odorizzi, G., Babst, M. and Emr, S. D. (2000). Phosphoinositide signaling and the regulation of membrane trafficking in yeast. Trends Biochem. Sci. 25,229 -235.[CrossRef][Medline]
Ogata, S. and Fukuda, M. (1994). Lysosomal
targeting of Limp II membrane glycoprotein requires a novel Leu-Ile motif at a
particular position in its cytoplasmic tail. J. Biol.
Chem. 269,5210
-5217.
Ohkuma, S. and Poole, B. (1981). Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J. Cell Biol. 90,656 -664.[Abstract]
Ohsumi, Y., Ishikawa, T. and Kato, K. (1983). A rapid and simplified method for the preparation of lysosomal membranes from rat liver. J. Biochem. (Tokyo) 93,547 -556.[Abstract]
Okazaki, I., Himeno, M., Ishikawa, T. and Kato, K. (1992). Purification and characterization of an 85kDa sialoglycoprotein in rat liver lysosomal membranes. J. Biochem. (Tokyo) 111,763 -769.[Abstract]
Peters, C. and von Figura, K. (1994). Biosynthesis of lysosomal membranes. FEBS Lett. 346,108 -114.[CrossRef][Medline]
Reaves, B. J., Bright, N. A., Mullock, B. M. and Luzio, J.
P. (1996). The effect of wortmannin on the localisation of
lysosomal type I integral membrane glycoproteins suggests a role for
phosphoinositide 3-kinase activity in regulating membrane traffic late in the
endocytic pathway. J. Cell Sci.
109,749
-762.
Robinson, M. S. and Bonifacino, J. S. (2001). Adaptor-related proteins. Curr. Opin. Cell Biol. 13,444 -453.[CrossRef][Medline]
Romagnoli, P., Layet, C., Yewdell, J., Bakke, O. and Germain, R. N. (1993). Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments. J. Exp. Med. 177,583 -596.[Abstract]
Rosenfeld, J. L., Moore, R. H., Zimmer, K.-P., Alpizar-Foster,
E., Dai, W., Zarka, M. N. and Knoll, B. J. (2001). Lysosome
proteins are redistributed during expression of a GTP-hydrolysis-defective
rab5a. J. Cell Sci. 114,4499
-4508.
Sandoval, I. V., Arredondo, J. J., Alcalde, J.,
Gonzalez-Noriega, A., Vandekerckhove, J., Jimenez, M. A. and Rico, M.
(1994). The residues Leu(Ile)475-Ile(Leu, Val,
Ala)476, contained in the extended carboxyl cytoplasmic tail, are
critical for targeting of the resident lysosomal membrane protein LIMP II to
lysosomes. J. Biol. Chem.
269,6622
-6631.
Shisheva, A., Sbrissa, D. and Ikonomov, O.
(1999). PIKfyve, a mammalian ortholog of yeast Fab1p lipid
kinase, synthesizes 5-phosphoinositides. Effect of insulin. Mol.
Cell. Biol. 19,623
-634.
Shisheva, A., Rusin, B., Ikonomov, O. C., DeMarco, C. and
Sbrissa, D. (2001). Localization and insulin-regulated
relocation of phosphoinositide 5-kinase PIKfyve in 3T3-L1 adipocytes.
J. Biol. Chem. 276,11859
-11869.
Simonsen, A., Lippe, R., Christoforidis, S., Gauller, J. M., Brech, A., Callaghan, J., Toh, B. H., Murphy, C., Zerial, M. and Stenmark, H. (1998). EEA1 links PI(3)k function to Rab5 regulation of endosome fusion. Nature 394,494 -498.[CrossRef][Medline]
Simonsen, A., Wurmser, A. E., Emr, S. D. and Stenmark, H. (2001). The role of phosphoinositides in membrane transport. Cuur. Opin. Cell Biol. 13,485 -492.
Stang, E. and Bakke, O. (1997). MHC class II-associated invariant chain-induced enlarged endosomal structures: A morphological study. Exp. Cell Res., 235, 79-92.[CrossRef][Medline]
Stoorvogel, W., Strous, G. J., Geuze, H. J., Oorschot, V. and Schwartz, A. L. (1991). Late endosomes derive from early endosomes by maturation. Cell 65,417 -427.[Medline]
Storrie, B. and Desjardins, M. (1996). The biogenesis of lysosomes: is it a kiss and run, continuous fusion and fission process? Bioessays 18,895 -903.[Medline]
van Deurs, B., Holm, P. K., Kayser, L., Sandvig, K. and Hansen, S. H. (1993). Multivesiclular bodies in Hep-2 cells are maturing endosomes. Eur. J. Cell Biol. 61,208 -224.[Medline]
Vega, M. A., Segui-Real, B., Alcalde-Garcia, J., Cales, C.,
Rodriguez, F., Vanderkerckhove, J. and Sandoval, I. V.
(1991). Cloning, sequencing, and expression of a cDNA encoding
rat LIMP II, a novel 74-kDa lysosomal membrane protein related to the surface
adhesion protein CD36. J. Biol. Chem.
266,16818
-16824.
Williams, M. A. and Fukuda, M. (1990). Accumulation of membrane glycoproteins in lysosomes requires a tyrosine residue at a particular position in the cytoplasmic tail. J. Cell Biol. 111,955 -966.[Abstract]
Wood, S. A. and Brown, W. J. (1992). The morphology, but not the function of endosomes and lysosomes is altered by brefeldin-A. J. Cell Biol. 119,273 -285.[Abstract]
Zerial, M. and McBride, H. (2001). Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2, 107-117.[CrossRef][Medline]
Related articles in JCS: